AIDS in the World charts a course into the future based on clear analysis of the global pandemic and response, lessons learned from the first decade, and understanding of the scientific and social dimensions of the HIV/AIDS challenge. It explains how the diversity of responses to the pandemic has contributed to a more specific understanding of the determinants of our vulnerability to HIV/AIDS, and provides a blueprint for an expanded global prevention effort. Aids in the World, published in 1992, was the first full analysis of mankind's global confrontation with this disease. The authors…mehr
AIDS in the World charts a course into the future based on clear analysis of the global pandemic and response, lessons learned from the first decade, and understanding of the scientific and social dimensions of the HIV/AIDS challenge. It explains how the diversity of responses to the pandemic has contributed to a more specific understanding of the determinants of our vulnerability to HIV/AIDS, and provides a blueprint for an expanded global prevention effort.Aids in the World, published in 1992, was the first full analysis of mankind's global confrontation with this disease. The authors chart a course into the future based on an incisive investigation of the global pandemic and response, the crucial lessons learned from the first decade, and their expert understanding of the scientific and social dimensions of the HIV challenge.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Jonathan M. Mann, M.D., M.P.H., is Francois-Xavier Bagnoud Professor of Health and Human Rights, Professor of Epidemiology and International Health, and Director of the Francois-Xavier Bagnoud Center for Health and Human Rights at Harvard University School of Public Health. Daniel J.M. Tarantola, M.D., is Senior Research Associate, Lecturer in Population and International Health, and Director of the International AIDS Program at the Francois-Xavier Bagnoud Center for Health and Human Rights, Harvard University School of Public Health.
Inhaltsangabe
* Part I: The State of the Pandemic and its Impact * 1.: N. Lapointe: A Global Overview * 2.: K.A. Stanecki, P.O. Way: The Dynamic HIV/AIDS Pandemic * 3.: B.G. Weniger, S. Berkley: The Evolving HIV/AIDS Pandemic * 4.: R.M. Anderson: The Spread of HIV and Sexual Mixing Patterns * 5.: M.C. Raviglione, P.P. Nunn, A. Kochi, R.J. O'Brien: The Pandemic of HIV-Associated Tuberculosis * 6.: B. Vuylsteke, R. Sunkutu, M. Laga: HIV/AIDS Among Women * 7.: A. Whiteside: The Economic Impact * 8.: R. Bayer: Societal and Political Impact of HIV/AIDS * Part II: The Frontiers of Knowledge * 9.: P. Gillies: YThe Contribution of Social and Behavioral Science to HIV/AIDS Prevention * 10.: E.E. Cooper: Treatment of HIV Disease: Problems, Progress, and Potential * 11.: R. Colebunders: Long-Term Survivors: What Can We Learn From Them? * 12.: K.M. De Cock, F. Brun-Vezinet: HIV-2 Infection: Current Knowldge and Uncertainties * 13.: J. Levy: HIV Heterogeneity in Transmission and Pathogenesis * 14.: D.P. Francis: HIV Vaccine Development: Progress and Problems * 15.: W.L. Heyward, S. Osmanov, J. Esparza: Preparing for HIV Vaccine Efficacy Trials in Developing Countries * 16.: C.J. Elias, L.L. Heise, E. Gollub: Women-Controlled HIV Prevention Methods * 17.: R. Widdus: Who Sets the Global Research Agenda for Biomedical Science? * 18.: A.J. Pinching: AIDS Research: Solidarity? Rivalry? Fraternity? * Part III: Individual and Population Responses * 19.: G. Rao Gupta, E. Weiss, D. Whelan: HIV/AIDS Among Women * 20.: Z.A. Stein, L. Kuhn: HIV in Women: What are the Gaps in Knowledge * 21.: N.D. Hoffman, M.D. Futterman: Youth and HIV/AIDS * 22.: A.P.M. Coxon, D. Altman: Homosexuality and HIV * 23.: A.A. Ehrhardt: Sexual Behavior Among Heterosexuals * 24.: D.C. DesJarlais, S.R. Friedman: Risk Reduction Among Injecting Drug Users * 25.: T.W. Harding: HIV.AIDS in Prison * 26.: S. LeCouer, M. Lallemant: Pediatric HIV/AIDS * 27.: C. Levine, D. Michaels, S. Back: Orphans of the HIV/AIDS Pandemic * 28.: N. Gilmore: Blood and Blood Product Safety * 29.: J.E. Osborn: Are We Learning from the Lessons of the Past? * Part IV: Collective Responses * 30.: J. Mann, D. Tarantola: Governmental National AIDS Programs * 31.: S. Gruskin, K. Tomasevski, A. Hendriks: Human Rights and Responses to HIV/AIDS * 32.: J. O'Malley, V.K. Nguyen, S. Lee: Nongovernmental Organizations * 33.: B. Bezalinovic: The Private Sector: How are Corporations Responding to HIV/AIDS? * 34.: L. Garbus: The UN Response * 35.: M. Laws: International Funding of the Global AIDS Strategy: Official Development Assistance * 36.: A. Martin: The Cost of HIV/AIDS Care * 37.: J. Broomberg, D. Schopper: Global Spending opn HIV/AIDS Prevention, Care, and Research Estimated Spendinbg on HIV Prevention * Part V: From Epidemiology to Vulnerability to Human Rights * 38.: S. Watney: The History of Discovery and Response * 39.: J. Mann: Personal Vulnerability and the Design of thje Programs * 40.: T. Barnett, R. Grellier: Societal Vulnerability : The Contextual Analysis * 41.: J. O'Malley: From Vulnerability to Human Rights * Appendix A: AIDS Cases Reported to the World Health Organization, by GAA and by Year, 1984-1996 * Appendix B: Method for the Estimation and Projection of HIV/AIDS * Appendix C: Repsonses to the Survey of Government National AIDS Programs * Appendix D: Laws and Practices in Relation to HIVB/AIDS: A Survey of Government National AIDS Program Managers * Appendix E: The Universal Declaration of Human Rights * Appendix F: Directory of Contact of Government National AIDS Programs
* Part I: The State of the Pandemic and its Impact * 1.: N. Lapointe: A Global Overview * 2.: K.A. Stanecki, P.O. Way: The Dynamic HIV/AIDS Pandemic * 3.: B.G. Weniger, S. Berkley: The Evolving HIV/AIDS Pandemic * 4.: R.M. Anderson: The Spread of HIV and Sexual Mixing Patterns * 5.: M.C. Raviglione, P.P. Nunn, A. Kochi, R.J. O'Brien: The Pandemic of HIV-Associated Tuberculosis * 6.: B. Vuylsteke, R. Sunkutu, M. Laga: HIV/AIDS Among Women * 7.: A. Whiteside: The Economic Impact * 8.: R. Bayer: Societal and Political Impact of HIV/AIDS * Part II: The Frontiers of Knowledge * 9.: P. Gillies: YThe Contribution of Social and Behavioral Science to HIV/AIDS Prevention * 10.: E.E. Cooper: Treatment of HIV Disease: Problems, Progress, and Potential * 11.: R. Colebunders: Long-Term Survivors: What Can We Learn From Them? * 12.: K.M. De Cock, F. Brun-Vezinet: HIV-2 Infection: Current Knowldge and Uncertainties * 13.: J. Levy: HIV Heterogeneity in Transmission and Pathogenesis * 14.: D.P. Francis: HIV Vaccine Development: Progress and Problems * 15.: W.L. Heyward, S. Osmanov, J. Esparza: Preparing for HIV Vaccine Efficacy Trials in Developing Countries * 16.: C.J. Elias, L.L. Heise, E. Gollub: Women-Controlled HIV Prevention Methods * 17.: R. Widdus: Who Sets the Global Research Agenda for Biomedical Science? * 18.: A.J. Pinching: AIDS Research: Solidarity? Rivalry? Fraternity? * Part III: Individual and Population Responses * 19.: G. Rao Gupta, E. Weiss, D. Whelan: HIV/AIDS Among Women * 20.: Z.A. Stein, L. Kuhn: HIV in Women: What are the Gaps in Knowledge * 21.: N.D. Hoffman, M.D. Futterman: Youth and HIV/AIDS * 22.: A.P.M. Coxon, D. Altman: Homosexuality and HIV * 23.: A.A. Ehrhardt: Sexual Behavior Among Heterosexuals * 24.: D.C. DesJarlais, S.R. Friedman: Risk Reduction Among Injecting Drug Users * 25.: T.W. Harding: HIV.AIDS in Prison * 26.: S. LeCouer, M. Lallemant: Pediatric HIV/AIDS * 27.: C. Levine, D. Michaels, S. Back: Orphans of the HIV/AIDS Pandemic * 28.: N. Gilmore: Blood and Blood Product Safety * 29.: J.E. Osborn: Are We Learning from the Lessons of the Past? * Part IV: Collective Responses * 30.: J. Mann, D. Tarantola: Governmental National AIDS Programs * 31.: S. Gruskin, K. Tomasevski, A. Hendriks: Human Rights and Responses to HIV/AIDS * 32.: J. O'Malley, V.K. Nguyen, S. Lee: Nongovernmental Organizations * 33.: B. Bezalinovic: The Private Sector: How are Corporations Responding to HIV/AIDS? * 34.: L. Garbus: The UN Response * 35.: M. Laws: International Funding of the Global AIDS Strategy: Official Development Assistance * 36.: A. Martin: The Cost of HIV/AIDS Care * 37.: J. Broomberg, D. Schopper: Global Spending opn HIV/AIDS Prevention, Care, and Research Estimated Spendinbg on HIV Prevention * Part V: From Epidemiology to Vulnerability to Human Rights * 38.: S. Watney: The History of Discovery and Response * 39.: J. Mann: Personal Vulnerability and the Design of thje Programs * 40.: T. Barnett, R. Grellier: Societal Vulnerability : The Contextual Analysis * 41.: J. O'Malley: From Vulnerability to Human Rights * Appendix A: AIDS Cases Reported to the World Health Organization, by GAA and by Year, 1984-1996 * Appendix B: Method for the Estimation and Projection of HIV/AIDS * Appendix C: Repsonses to the Survey of Government National AIDS Programs * Appendix D: Laws and Practices in Relation to HIVB/AIDS: A Survey of Government National AIDS Program Managers * Appendix E: The Universal Declaration of Human Rights * Appendix F: Directory of Contact of Government National AIDS Programs
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
